DNJC8_HUMAN - dbPTM
DNJC8_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DNJC8_HUMAN
UniProt AC O75937
Protein Name DnaJ homolog subfamily C member 8
Gene Name DNAJC8
Organism Homo sapiens (Human).
Sequence Length 253
Subcellular Localization Nucleus .
Protein Description Suppresses polyglutamine (polyQ) aggregation of ATXN3 in neuronal cells. [PubMed: 27133716]
Protein Sequence MAASGESGTSGGGGSTEEAFMTFYSEVKQIEKRDSVLTSKNQIERLTRPGSSYFNLNPFEVLQIDPEVTDEEIKKRFRQLSILVHPDKNQDDADRAQKAFEAVDKAYKLLLDQEQKKRALDVIQAGKEYVEHTVKERKKQLKKEGKPTIVEEDDPELFKQAVYKQTMKLFAELEIKRKEREAKEMHERKRQREEEIEAQEKAKREREWQKNFEESRDGRVDSWRNFQANTKGKKEKKNRTFLRPPKVKMEQRE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAASGESGT
------CCCCCCCCC
15.4419413330
4Phosphorylation----MAASGESGTSG
----CCCCCCCCCCC
33.2923401153
7Phosphorylation-MAASGESGTSGGGG
-CCCCCCCCCCCCCC
51.3924043423
9PhosphorylationAASGESGTSGGGGST
CCCCCCCCCCCCCCH
33.2128348404
10PhosphorylationASGESGTSGGGGSTE
CCCCCCCCCCCCCHH
38.6828348404
15PhosphorylationGTSGGGGSTEEAFMT
CCCCCCCCHHHHHHH
35.6025849741
16PhosphorylationTSGGGGSTEEAFMTF
CCCCCCCHHHHHHHH
40.9128348404
22PhosphorylationSTEEAFMTFYSEVKQ
CHHHHHHHHHHHHHH
16.9924043423
24PhosphorylationEEAFMTFYSEVKQIE
HHHHHHHHHHHHHHH
8.5124043423
25PhosphorylationEAFMTFYSEVKQIEK
HHHHHHHHHHHHHHH
31.5524043423
35PhosphorylationKQIEKRDSVLTSKNQ
HHHHHHHCCCCCHHH
24.0630266825
38PhosphorylationEKRDSVLTSKNQIER
HHHHCCCCCHHHHHH
35.1823403867
39PhosphorylationKRDSVLTSKNQIERL
HHHCCCCCHHHHHHH
26.0023403867
402-HydroxyisobutyrylationRDSVLTSKNQIERLT
HHCCCCCHHHHHHHC
47.86-
40UbiquitinationRDSVLTSKNQIERLT
HHCCCCCHHHHHHHC
47.8632015554
47PhosphorylationKNQIERLTRPGSSYF
HHHHHHHCCCCCCCC
40.8328450419
51PhosphorylationERLTRPGSSYFNLNP
HHHCCCCCCCCCCCH
25.2528450419
52PhosphorylationRLTRPGSSYFNLNPF
HHCCCCCCCCCCCHH
39.3928450419
53PhosphorylationLTRPGSSYFNLNPFE
HCCCCCCCCCCCHHC
9.7428122231
74UbiquitinationEVTDEEIKKRFRQLS
CCCHHHHHHHHHHHH
40.9729967540
75AcetylationVTDEEIKKRFRQLSI
CCHHHHHHHHHHHHH
63.537265649
81PhosphorylationKKRFRQLSILVHPDK
HHHHHHHHHHCCCCC
12.9229514088
88AcetylationSILVHPDKNQDDADR
HHHCCCCCCCCHHHH
62.0425953088
105AcetylationKAFEAVDKAYKLLLD
HHHHHHHHHHHHHCC
47.2025953088
105UbiquitinationKAFEAVDKAYKLLLD
HHHHHHHHHHHHHCC
47.2022817900
107PhosphorylationFEAVDKAYKLLLDQE
HHHHHHHHHHHCCHH
14.1228674151
108AcetylationEAVDKAYKLLLDQEQ
HHHHHHHHHHCCHHH
37.2025953088
108UbiquitinationEAVDKAYKLLLDQEQ
HHHHHHHHHHCCHHH
37.2022817900
1162-HydroxyisobutyrylationLLLDQEQKKRALDVI
HHCCHHHHHHHHHHH
43.40-
116UbiquitinationLLLDQEQKKRALDVI
HHCCHHHHHHHHHHH
43.4029967540
117UbiquitinationLLDQEQKKRALDVIQ
HCCHHHHHHHHHHHH
42.4724816145
118MethylationLDQEQKKRALDVIQA
CCHHHHHHHHHHHHH
47.63-
118DimethylationLDQEQKKRALDVIQA
CCHHHHHHHHHHHHH
47.63-
1272-HydroxyisobutyrylationLDVIQAGKEYVEHTV
HHHHHHHHHHHHHHH
49.22-
127UbiquitinationLDVIQAGKEYVEHTV
HHHHHHHHHHHHHHH
49.2233845483
129PhosphorylationVIQAGKEYVEHTVKE
HHHHHHHHHHHHHHH
18.0228152594
133PhosphorylationGKEYVEHTVKERKKQ
HHHHHHHHHHHHHHH
21.5528152594
135UbiquitinationEYVEHTVKERKKQLK
HHHHHHHHHHHHHHH
53.6224816145
135AcetylationEYVEHTVKERKKQLK
HHHHHHHHHHHHHHH
53.6223749302
143UbiquitinationERKKQLKKEGKPTIV
HHHHHHHHCCCCCCC
79.0629967540
143AcetylationERKKQLKKEGKPTIV
HHHHHHHHCCCCCCC
79.0626822725
146AcetylationKQLKKEGKPTIVEED
HHHHHCCCCCCCCCC
39.8319608861
146UbiquitinationKQLKKEGKPTIVEED
HHHHHCCCCCCCCCC
39.8319608861
159AcetylationEDDPELFKQAVYKQT
CCCHHHHHHHHHHHH
50.3926051181
159UbiquitinationEDDPELFKQAVYKQT
CCCHHHHHHHHHHHH
50.3929967540
1762-HydroxyisobutyrylationLFAELEIKRKEREAK
HHHHHHHHHHHHHHH
48.30-
176UbiquitinationLFAELEIKRKEREAK
HHHHHHHHHHHHHHH
48.3033845483
201UbiquitinationEEIEAQEKAKREREW
HHHHHHHHHHHHHHH
47.3224816145
210UbiquitinationKREREWQKNFEESRD
HHHHHHHHHHHHHCC
65.7529967540
215PhosphorylationWQKNFEESRDGRVDS
HHHHHHHHCCCCCCC
28.5923403867
222PhosphorylationSRDGRVDSWRNFQAN
HCCCCCCCHHHHHCC
25.6923401153
224MethylationDGRVDSWRNFQANTK
CCCCCCHHHHHCCCC
37.73-
230PhosphorylationWRNFQANTKGKKEKK
HHHHHCCCCCCCCCC
44.16-
231UbiquitinationRNFQANTKGKKEKKN
HHHHCCCCCCCCCCC
69.4227667366
237UbiquitinationTKGKKEKKNRTFLRP
CCCCCCCCCCCCCCC
53.4024816145
239MethylationGKKEKKNRTFLRPPK
CCCCCCCCCCCCCCC
35.42-
240PhosphorylationKKEKKNRTFLRPPKV
CCCCCCCCCCCCCCC
36.0928555341
243MethylationKKNRTFLRPPKVKME
CCCCCCCCCCCCCHH
41.08-
248SumoylationFLRPPKVKMEQRE--
CCCCCCCCHHHCC--
42.73-
248SumoylationFLRPPKVKMEQRE--
CCCCCCCCHHHCC--
42.73-
248UbiquitinationFLRPPKVKMEQRE--
CCCCCCCCHHHCC--
42.7324816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DNJC8_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DNJC8_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DNJC8_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
RAP1A_HUMANRAP1Aphysical
22939629
PIN4_HUMANPIN4physical
22939629
TPX2_HUMANTPX2physical
22939629
HMGA1_HUMANHMGA1physical
18850631
HS74L_HUMANHSPA4Lphysical
26344197
HYOU1_HUMANHYOU1physical
26344197
NEDD8_HUMANNEDD8physical
26344197
TRAP1_HUMANTRAP1physical
27173435
SND1_HUMANSND1physical
27173435
ANXA5_HUMANANXA5physical
27173435
UBE2N_HUMANUBE2Nphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DNJC8_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-146, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215, AND MASSSPECTROMETRY.

TOP